NCT02183701View on ClinicalTrials.gov

Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

715

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

December 31, 1998

Conditions
Hypertension
Interventions
DRUG

Telmisartan

DRUG

Losartan + Hydrochlorothiazide

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY